Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up : Importance of patient selection and implant qualityKOLLMEIER, Marisa A; STOCK, Richard G; STONE, Nelson et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 3, pp 645-653, issn 0360-3016, 9 p.Article

How to select the optimal therapy for early-stage prostate cancerKOLLMEIER, Marisa A; ZELEFSKY, Michael J.Critical reviews in oncology/hematology. 2012, Vol 83, Num 2, pp 225-234, issn 1040-8428, 10 p.Article

Long-Term Outcome Following Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy for Clinical Stage T3 Prostate CancerZELEFSKY, Michael J; YAMADA, Yoshiya; KOLLMEIER, Marisa A et al.European urology. 2008, Vol 53, Num 6, pp 1172-1179, issn 0302-2838, 8 p.Article

Combined modality treatment in the management of high-risk prostate cancerSTOCK, Richard G; CAHLON, Oren; CESARETTI, Jamie A et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 5, pp 1352-1359, issn 0360-3016, 8 p.Article

Dose Escalation for Prostate Cancer Radiotherapy: Predictors of Long-Term Biochemical Tumor Control and Distant Metastases―Free Survival OutcomesZELEFSKY, Michael J; XIN PEI; ZHIGANG ZHANG et al.European urology. 2011, Vol 60, Num 6, pp 1133-1139, issn 0302-2838, 7 p.Article

Patterns and Predictors of Amelioration of Genitourinary Toxicity After High-dose Intensity-modulated Radiation Therapy for Localized Prostate Cancer: Implications for Defining Postradiotherapy Urinary ToxicityGHADJAR, Pirus; JACKSON, Andrew; SPRATT, Daniel E et al.European urology. 2013, Vol 64, Num 6, pp 931-938, issn 0302-2838, 8 p.Article

A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation TherapyZUMSTEG, Zachary S; SPRATT, Daniel E; PEI, Isaac et al.European urology. 2013, Vol 64, Num 6, pp 895-902, issn 0302-2838, 8 p.Article

Long-Term Outcomes After High-Dose Postprostatectomy Salvage Radiation TreatmentGOENKA, Anuj; MAGSANOC, Juan Martin; XIN PEI et al.International journal of radiation oncology, biology, physics. 2012, Vol 84, Num 1, pp 112-118, issn 0360-3016, 7 p.Article

Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function in Men Treated with Radiotherapy for Prostate CancerZELEFSKY, Michael J; SHASHA, Daniel; BRANCO, Rebekah Dunn et al.The Journal of urology. 2014, Vol 192, Num 3, pp 868-874, issn 0022-5347, 7 p.Article

Improved Clinical Outcomes With High-Dose Image Guided Radiotherapy Compared With Non-IGRT for the Treatment of Clinically Localized Prostate CancerZELEFSKY, Michael J; KOLLMEIER, Marisa; COX, Brett et al.International journal of radiation oncology, biology, physics. 2012, Vol 84, Num 1, pp 125-129, issn 0360-3016, 5 p.Article

Incidence of Secondary Cancer Development After High-Dose Intensity-Modulated Radiotherapy and Image-Guided Brachytherapy for the Treatment of Localized Prostate CancerZELEFSKY, Michael J; HOUSMAN, Douglas M; ZHIGANG ZHANG et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 3, pp 953-959, issn 0360-3016, 7 p.Article

Secondary cancers after intensity―modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause―specific survival outcomes according to the initial treatment interventionZELEFSKY, Michael J; XIN PEI; TESLOVA, Tatiana et al.BJU international (Papier). 2012, Vol 110, Num 11, pp 1696-1701, issn 1464-4096, 6 p.Article

Ten-Year Outcomes of High-Dose, Intensity-Modulated Radiotherapy for Localized Prostate CancerALICIKUS, Zumre A; YAMADA, Yoshiya; ZHIGANG ZHANG et al.Cancer. 2011, Vol 117, Num 7, pp 1429-1437, issn 0008-543X, 9 p.Article

Real-time Intraoperative Computed Tomography Assessment of Quality of Permanent Interstitial Seed Imalantation for Prostate CancerZELEFSKY, Michael J; WORMAN, Mick; ZAIDER, Marco et al.Urology (Ridgewood, NJ). 2010, Vol 76, Num 5, pp 1138-1142, issn 0090-4295, 5 p.Article

Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancerKOLLMEIER, Marisa A; FIDALEO, Anthony; XIN PEI et al.BJU international (Papier). 2013, Vol 111, Num 8, pp 1231-1236, issn 1464-4096, 6 p.Article

Pretreatment Endorectal Coil Magnetic Resonance Imaging Findings Predict Biochemical Tumor Control in Prostate Cancer Patients Treated With Combination Brachytherapy and External-Beam RadiotherapyRIAZ, Nadeem; AFAQ, Asim; AKIN, Oguz et al.International journal of radiation oncology, biology, physics. 2012, Vol 84, Num 3, pp 707-711, issn 0360-3016, 5 p.Article

Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancerSPRATT, Daniel E; ZUMSTEG, Zachary S; GHADJAR, Pirus et al.BJU international (Papier). 2014, Vol 114, Num 3, pp 360-367, issn 1464-4096, 8 p.Article

IMPROVED BIOCHEMICAL OUTCOMES WITH STATIN USE IN PATIENTS WITH HIGH-RISK LOCALIZED PROSTATE CANCER TREATED WITH RADIOTHERAPYKOLLMEIER, Marisa A; KATZ, Matthew S; MAK, Kimberley et al.International journal of radiation oncology, biology, physics. 2011, Vol 79, Num 3, pp 713-718, issn 0360-3016, 6 p.Article